Reconstituting semaglutide for injection requires precise measurement of bacteriostatic water. The specific volume depends on the concentration of the semaglutide powder provided and the desired final dose. Pharmaceutical guidelines or package inserts accompanying the medication provide the precise reconstitution instructions. Typically, a prescribed amount of bacteriostatic water is drawn into a syringe and injected into the vial containing the semaglutide powder. The vial is then gently swirled to ensure complete dissolution, avoiding vigorous shaking which can denature the medication. This process yields a solution ready for subcutaneous injection.
Accurate reconstitution is crucial for delivering the correct therapeutic dose. Using an incorrect volume of diluent can result in under- or over-dosing, impacting the effectiveness and safety of the treatment. Under-dosing may lead to inadequate glycemic control, while over-dosing increases the risk of adverse effects. Historically, the use of bacteriostatic water for reconstitution has been favored for multi-dose vials due to its preservative properties, extending the shelf life of the reconstituted medication. However, single-use vials, which do not require preservatives, are increasingly common.